Quantitative Molecular Imaging of Neuronal Nicotinic Acetylcholine Receptors in the Human Brain with A-85380 Radiotracers

Author(s): Shahrdad Lotfipour, Mark Mandelkern, Arthur L. Brody

Journal Name: Current Medical Imaging
Formerly: Current Medical Imaging Reviews

Volume 7 , Issue 2 , 2011

Become EABM
Become Reviewer


Neuronal nicotinic acetylcholine receptors (nAChRs) have been implicated in a spectrum of cognitive functions as well as psychiatric and neurodegenerative disorders, including tobacco addiction and Alzheimer's Disease. The examination of neuronal nAChRs in living humans is a relatively new field. Researchers have developed brain-imaging radiotracers for nAChRs, with radiolabeled A-85380 compounds having the most widespread use. We provide a brief background on nAChRs, followed by a discussion of the development and application of A-85380 radiotracers in human imaging studies. We describe potential future studies using nicotinic receptor radioligands for the study of tobacco addiction, including the mechanism of action of the smoking-cessation therapy varenicline. Throughout this review, we focus on the significant potential that resides in the identification and quantification of nAChRs in the living human brain.

Keywords: Nicotinic acetylcholine receptors, positron emission tomography, single-photon emission computed tomography, human brain imaging, tobacco dependence, varenicline, 2FA, 5IA, A-85380, endogenous, neurotransmitter, Toxicology

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [107 - 112]
Pages: 6
DOI: 10.2174/157340511795445676
Price: $65

Article Metrics

PDF: 5